| Patent Number |
Title Of Patent |
Date Issued |
| RE38934 |
Method and reagents for N-alkylating ureides |
January 10, 2006 |
| A method of N-alkoxyalkylating ureides according to the invention comprises reacting a ureide of structure I ##STR00001## with an alkylating agent of structure III ##STR00002## in the presence of a basic catalyst in an aprotic reaction medium. The ureide may be a 5,5-disubstitute |
| D493571 |
Nit comb |
July 27, 2004 |
|
| D483478 |
Spoon |
December 9, 2003 |
|
| 7064205 |
Process for preparing 1-methoxymethyl-5,5-diphenylbarbituric acid |
June 20, 2006 |
| The present invention provides a novel process for preparing 1-methoxymethyl-5,5-diphenylbarbituric acid. In particular, the present invention provides a process for preparing 1-methoxymethyl-5,5-diphenylbarbituric acid by reacting 1,3-bis(methoxymethyl)-5,5-diphenylbarbituric acid w |
| 6756379 |
Non-sedating barbiturate compounds as neuroprotective agents |
June 29, 2004 |
| Methods of providing neuroprotection are disclosed comprising administering a non-sedative barbiturate compound in an amount sufficient to achieve neuroprotection in a mammalian subject. Preferred compounds are in the family of diphenylbarbituric acid and analogs. Preferred doses for a |
| 6745919 |
Container for dispensing spill-resistant formulations |
June 8, 2004 |
| An article of manufacture comprises a) a squeezable bottle having an outlet, b) a plug in the bottle, the plug comprising an upper surface with a protruding nipple having a neck, and a top and an orifice communicating with a smooth tubular channel sized to permit a semi-solid formulation |
| 6673944 |
Preparation of warfarin sodium from warfarin acid |
January 6, 2004 |
| The invention provides a method for the direct preparation of pure warfarin sodium from warfarin acid. The reaction is conducted in a polar organic solvent, preferably ethanol, using a volatilizable base, preferably sodium bicarbonate or sodium carbonate, at low temperature. Drying the f |
| 6656482 |
Spill resistant pharmaceutical system |
December 2, 2003 |
| A spill-resistant pharmaceutical formulation for oral administration from a squeezable container comprises a pharmaceutical agent in a suitable vehicle comprising a liquid base and a thickening agent, the formulation consisting of mutually compatible components and having the following |
| 6610862 |
Preparation of warfarin sodium from warfarin sodium-2-propanol clathrate by solvent expulsion |
August 26, 2003 |
| The present invention is a method for producing warfarin sodium from warfarin sodium 2-propanol clathrate by thermal, nondestructive solvent expulsion. The solvent expulsion is conducted under conditions of controlled heat transfer whereby the 2-propanol is expelled from the warfarin |
| 6512005 |
Process for synthesis of pure warfarin acid, warfarin alkali metal salts and corresponding clath |
January 28, 2003 |
| An improved procedure for the purification of warfarin acid. Sodium, potassium and lithium warfarin salts and the corresponding clathrates are prepared in high, pharnacopeial grade purity and good yields from the pure warfarin acid and the respective metal salt bases in suitable media. |
| 6162466 |
Sustained release formulation of carbamazepine |
December 19, 2000 |
| The present invention provides a pharmaceutical preparation in tablet form, where the active ingredient is an anti-epileptic medication, preferably a sustained release formulation, and most preferably a sustained release formulation where the active ingredient is carbamazepine. The produ |
| 6093820 |
Method and reagents for N-alkylating ureides |
July 25, 2000 |
| A method of N-alkoxyalkylating ureides according to the invention comprises reacting a ureide of structure I ##STR1## with an alkylating agent of structure III ##STR2## in the presence of a basic catalyst in an aprotic reaction medium. The ureide may be a 5,5-disubstituted ba |
| 5599929 |
Method for preparing opipramol |
February 4, 1997 |
| An improved method for preparing opipramol (I) is disclosed, wherein iminostilbene (II) is reacted with 1-bromo-3-chloropropane in the presence of a weak base selected from a hydrogen phosphate salt and an acetate salt and in the presence of a phase transfer agent to produce N-(3-hal |
